Mallinckrodt, the soon-to-be spun-out pharma business of Covidien, is buying a Minnesota company that is developing drugs to treat neurological disorders and severe chronic pain by delivering them to specific locations in the central nervous system. The Hazelwood, Missouri unit of Covidien announced Monday that it is acquiring CNS Therapeutics’ outstanding capital stock for $100 […]
Envoy Medical, the St. Paul, Minnesota medical device startup, appears to be having some growing pains. Back in March 2010, it won the regulatory approval for the world’s first, fully implantable hearing aid system. Since then, Envoy, which has raised upward of $100 million to bring the Esteem device to market, has seen its share […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LabCorp (NYSE:LH) is set to acquire toxicology testing company MEDTOX Scientific (NASDAQ:MTOX) for $241 million as the laboratory testing and diagnostics firm builds out its specialty testing offerings. The definitive merger agreement calls for LabCorp to acquire MEDTOX for $27 per share in cash. That represents a 37 percent premium over MEDTOX’s $19.70 closing price […]
A newfangled enlarged prostate treatment is being tested at a Minnesota company, which hopes to be an alternative to failed drugs therapy or surgery in managing benign prostatic hyperplasia (BPH). NxThera, based in St. Paul, is testing Rezum, a device that uses steam or vapor to target the enlarged tissue of the prostate gland. This therapy […]
A St. Louis, Missouri medical device company is raising money in preparation for clinical trials of its pain-free cardioversion therapy for atrial fibrillation, developed by a former Case Western Reserve University researcher. CardiaLen Inc. has secured $2.4 million for its implantable low-voltage atrial cardioverter, technology developed by Prof. Igor Efimov and licensed from Washington University […]
Interim CEO Gregg Lehman at Angeion (NASDAQ:ANGN) has been retained as chief executive of the the St. Paul, Minnesota, company that designs, manufactures and distributes cardiorespiratory diagnostic systems. Lehman joined the company in May following the sudden (some believe forced) departure of its previous CEO Phil Smith after just six months on the job. The previous […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
BioMedix, a health IT firm based in St. Paul, Minnesota, named John Martin as medical director. BioMedix sells an integrated suite of hardware, software and online services that can detect peripheral arterial disease and chronic venous insufficiency cost-effectively. A company news release stated that Martin is “one of the only board certified vascular surgeons in […]
A Rhode Island medical development and contract manufacturing firm is opening an office at the St. Paul, Minnesota-based incubator University Enterprise Labs. Ximedica announced Tuesday that the company’s new Minnesota location will serve as a central hub for its healthcare client base in the Midwest. Its corporate headquarters are in Providence and it also has […]
St. Jude Medical (NYSE:STJ) is introducing two new cardiac devices in India, following a recent report that it plans to launch four in that populous Southeast Asian nation. The company’s Indian operations announced Monday that new, smaller scale Unify cardiac resynchronisation therapy defibrillators (CRT-D) and Fortify implantable cardioverter defibrillators (ICD) are “the smallest available device […]
A day after shaking up its senior management, Angeion Corp. reported flat revenue in its second fiscal quarter and a narrowed loss. The company reversed its decision to hold its routine conference call with analysts — something that was reiterated in a May 16 news release — implying that CEO Phil Smith’s departure after less […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Synovis Life Technologies Inc. announced Wednesday that the company had both top-line and bottom-line growth in its fiscal second quarter ended April 30. The St. Paul, Minnesota-based company saw revenue climb 12.6 percent to $19.8 million in the quarter, up from $17.6 million in the same quarter a year ago. Profits jumped 57.5 percent to […]
Update: 1:45 p.m. St. Paul, Minnesota-based public company Angeion Corp. made a surprising announcement this morning. CEO Phillip Smith is leaving the company after less than six months on the job. In a tersely worded statement, the company said Smith resigned after he and Angeion’s board reached a “mutual decision.” This is all the more […]
A British company is alleging that diversified conglomerate 3M Co. sabotaged a device that it sold to the St. Paul, Minnesota company in favor of bringing 3M’s own, more expensive solution to the market. Five years ago, the Porton Group sold 3M a potential breakthrough device called the BacLite, which uses a special fluorescent light […]
St. Paul-based Angeion Corp. named Rob Wolf its chief financial officer and Mark Gryzwa its vice president of engineering effective Monday. Wolf and Gryzwa will report to Phil Smith, the CEO of Angeion, the St. Paul, Minnesota company that makes noninvasive cardiorespiratory diagnostic systems. Wolf replaces Larry Degen, Angeion’s interim CFO, who will continue with […]
St.Paul, Minnesota-based St. Jude Medical (NYSE:STJ) announced Wednesday that the Food & Drug Administration has approved a new pericardial aortic stented tissue valve — the Trifecta. In a statement, the company said that the Trifecta valve was designed to optimize the flow of blood through the valve and for long-term durability. To ensure the structural […]